Skip to main content

Table 1 Demographics of subjects used

From: Mitochondrial tRNA methylation in Alzheimer’s disease and progressive supranuclear palsy

Diagnosis Sex Age at Death APOE
e2 e3 e4
NC (n = 74) Male (n = 40) 80.93 ± 8.15 7.43% 86.40% 6.08%
Female (n = 34) 85.15 ± 6.76    
AD (n = 82) Male (n = 34) 81.68 ± 8.17 2.44% 68.30% 29.30%
Female (n = 48) 83.21 ± 7.19    
PSP (n = 83) Male (n = 51) 74.22 ± 6.94 9.04% 82.53% 8.43%
Female (n = 32) 73.65 ± 5.99    
PA (n = 27) Male (n = 11) 85.18 ± 3.74 7.41% 75.92% 16.67%
Female (n = 16) 84.06 ± 4.65    
  1. Age is reported as an average ± standard deviation for each respective group. Normal control (NC), Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), pathological aging (PA).